There are few specific data available concerning quality of life (QOL) of survivors of unrelated donor bone marrow transplantation (UD-BMT). The procedure is expensive, difficult and is being employed increasingly yet we have little information concerning the QOL of survivors to justify this intervention. In this study, 20 long-term (Ͼ1 year post-BMT) survivors were studied with four self report questionnaires designed to assess quality of life, satisfaction with life, social support and employment status. Overall, satisfaction with life measures was above average but there was dissatisfaction with physical strength and appearance. The post-transplant employment data indicates that 60% of long-term survivors returned to full-time work and 15% to parttime work. Failure to return to work was not correlated with graft-versus-host disease (GVHD), relapse, age at or time since transplant. In general, there was a good correlation between the clinician's and patient's view of their health but the clinician's assessment of the patients mental health and energy was higher than the patients reported. Further research is required in the area of QOL post-UD-BMT. This will enable transplant physicians to counsel patients better pre-BMT and to evaluate fully the results achieved by different centres performing the procedure. Keywords: unrelated donor BMT; quality of life; employment; long-term survivor; social support Unrelated donor bone marrow transplantation (UD-BMT) is being used with increasing frequency as curative therapy for a variety of haematological malignancies and nonhaematological conditions 1 and results are improving.
Unrelated donor bone marrow transplantation (UD-BMT) is being used with increasing frequency as curative therapy for a variety of haematological malignancies and nonhaematological conditions 1 and results are improving. 2 Some recent survival figures reported approach those seen with sibling allografts. 2 A consensus conference has recently debated the role of UD-BMT in the management of haematological diseases, however its use remains controversial amongst haematologists. 3 There is still disagreement about outcomes and there are very few data about the quality of life of survivors. 4, 5 Quality of life of those surviving BMT may depend on Correspondence: DI Marks, Bone Marrow Transplant Unit, United Bristol Healthcare Trust, St Michael's Hill, Bristol BS2 8BJ, UK Received 14 December 1998; accepted 21 February 1999 many things including remission status, presence or absence of chronic GVHD, 4 emotional state, social support, 6 ,7 sexual function 4, 5 and in many cases employment status. 8 Furthermore, survivors of UD-BMT may experience a different quality of life to survivors of other types of stem cell transplant. The chance of transplant-related mortality is higher and most transplant-associated complications are more common. These include graft failure, infection and extensive chronic GVHD. 4 These complications result in longer initial inpatient stays and more frequent readmissions (Marks, unpublished data) . In addition, the time-consuming, expensive search for an unrelated donor may impose additional emotional pressures on the patient. Finally, a physician's view of a patient's QOL may not reflect the patient's perceptions. It has sometimes been our experience that different observers 9 have formed quite different views of the progress of patients post-transplant. In previous QOL surveys we have conducted, patients have sometimes reported symptoms and problems that we had not suspected clinically.
In this study, we sought to examine selected aspects of the quality of life of patients surviving more than 1 year post-UD-BMT and compare this with the perceptions of their treating clinician. One important QOL measure that we examined was post-BMT employment status. Although a number of non-medical factors may influence this, return to work represents a landmark in a patient's recovery from transplant and it remains an important parameter to use in comparing results of different UD-BMT series.
Methods

Patients and eligibility
Between June 1991 and June 1996, 52 adults (aged 17 years or more) received stem cells from an unrelated donor in the BMT unit at the United Bristol Healthcare Trust. Twenty-two patients were alive more than 1 year post-UD-BMT; attempts were made to contact all patients and 20 gave informed consent to participate in the study (two patients were overseas and could not be contacted).
Basic demographic and transplant-related data were collected from the BMT database and patient records. These included age, gender, relationship status, diagnosis, time since transplant, age at transplant, years post-transplant, presence and grade of GVHD ( our transplant protocols have been previously published in detail; 10 in general they include cyclophosphamide, total body irradiation and some method of T cell depletion of the graft.
Questionnaires
Four questionnaires were mailed to patients and their consultant clinician (DM) was asked to fill out a questionnaire concerning the patients' health. This questionnaire was based on the eight main areas of the SF-36. All these measures have been validated in the BMT setting.
Medical outcomes survey -short form (MOS-SF36): The MOS-SF36
11 has been used in a variety of cancer patients and is a self report survey of subjective health related quality of life. It evaluates physical functioning, physical and emotional role functioning, social functioning, bodily pain, mental health, vitality and general health. Each of the eight factors has a summary score and higher scores indicate a better quality of life. 12 The short form has a 0.95 correlation with the original full length scales, indicating its stability.
Satisfaction with life domains scale for cancer (SLDS-C):
The SLDS-C was validated in 109 BMT patients. 13 Its 17 domains were selected to include aspects of life likely to be affected by cancer and its treatment. Ratings range from satisfied (seven) to not satisfied (one). There is a cronbach alpha rating of 0.93.
Significant others scale (SOS):
Social support encompasses a wide range of informal relationships between the patient and other people. The SOS is the measure selected to evaluate the role of practical and emotional support in overall coping. It focuses on perceived support rather than received support.
14 It has scales that focus on partners, daughters and sons, siblings, best friends and important relatives.
Employment:
The questions for this questionnaire were derived from previous studies of the employment-related problems these patient encounter. 15, 16 The clinician completed an 8 part questionnaire which was derived from the SF36 and concerned ratings of the following: physical functioning, limitations at work, limi- All other items rated 4.70 or more out of a maximum of 7. *P Ͻ 0.05. **P Ͻ 0.01. tations in social activities, mental state, mental health, energy levels, pain, general health, comparison to health a year ago.
Statistics
All descriptive and inferential statistics were performed using SPSS for windows (version 6.1). Pearson's product moment correlations were calculated to assess the relationships between the SLDS-C and measures of employment and GVHD and relapse. Further correlational analyses were performed to assess the relationship between the clinician's and patient's perception of the patient's health. Similar correlational analyses were made between the measure of social support and the SF-36 to examine the relationship between support and health-related quality of life. Analysis of variance (ANOVA) were conducted to assess the relationship between the demographic variables, employment and the SLDS-C. Post-hoc testing (Tukeys Honestly Significant Difference) was also performed.
Results
Satisfaction with life domain scale
Although in over half the items of the SLDS-C the patients were more satisfied than average, they were dissatisfied with certain aspects of their life (Table 2 ). These items related to physical strength and appearance. Satisfaction with one's body correlated negatively with GVHD (r = 193 Table 4 Mean scores of different aspects of the significant others scale −0.573, P Ͻ 0.05) and relapse (r = −0.529, P Ͻ 0.05). A significant proportion of patients were dissatisfied with their sexual function.
Comparison between clinician's and patients' view of their health
There was a significant correlation for seven of the nine MOS-SF36 subscales between the clinician's and patients' perception of their health (Table 3) . There were however, significant negative correlations for energy/vitality and mental health.
Social support
The overall level of social support was high ( Table 4 ). The two major sources of social support were a partner and then an 'important relative'. The ideal level of support was higher than that received. The biggest discrepancies were for siblings and best friends. Actual social support was found to correlate with energy/vitality (0.518) and mental health (0.524, both P Ͻ 0.05). Actual social support was found to correlate with many of the indices of the quality of life scale (SLDS-C) ( Table 5 ).
Employment
Although 30% fewer patients were in full-time employment post-BMT as compared to their pre-illness status, it is heartening that 75% had some form of employment post-trans- plant (Table 6 ). The majority of unemployed patients reported being too unwell to work but one patient felt that the major reason was not due to his health but that his job was too strenuous. There was no correlation between GVHD and relapse and the inability to work. Nor was there any correlation between employment status and age at transplant or time since transplant. Significant numbers of patients felt it had affected their job plans and a quarter had been denied new tasks or experienced undesirable transfer or demotion. These problems did not seem to stem from negative feelings from colleagues. The extent to which illness affected job plans was negatively correlated with quality of life (r = −0.5822, P Ͻ 0.01).
Influence of graft-versus-host disease
Graft-versus-host disease had a profound influence on several aspects of the SLDS-C. These included health, daily activities, strength and overall quality of life (all significant at the Ͻ0.01 level). Post-hoc testing (a comparison of the three groups with no, mild and severe GVHD) confirmed the significant influence of GVHD on the overall quality of life. It had less significant effects (P Ͻ 0.05) on friends, body, leisure time, control and life as a whole. Three aspects of the MOS-SF36 were significantly (P Ͻ 0.01) affected by the presence of GVHD. These were health perceptions, pain and physical functioning.
Discussion
Unrelated donor bone marrow transplantation has only been a commonly performed procedure for about 10 years. Many problems exist, and the initial focus has been on improving survival figures.
1 Only more recently have efforts been made to investigate the psychosocial impact of transplant and the quality of life of long-term survivors. 17 Perhaps the most impressive recent paper on UD-BMT is the Seattle group's report on 196 patients with CML in first chronic phase.
2 Fifty-seven percent of patients are alive at 5 years (although some better prognosis groups are defined) but fully two-thirds of evaluable patients experienced extensive chronic GVHD; this will necessarily have affected their QOL. A significant percentage of patients with chronic GVHD were able eventually to discontinue their immunosuppression but it is not clear how many of these have compromised organ function. About one quarter have a significantly impaired Karnofsky score 3 years post-BMT but there are no data regarding employment or other more detailed measures of QOL. The Hammersmith group reported that there was a trend towards a worse performance status in recipients of UD-BMT as compared to sibling BMT. 4 Many of their survivors with abnormal performance status had chronic GVHD and this made them unable to work. The group examined in this study reported an above average level of satisfaction with most of the life domains but remained dissatisfied with measures related to their bodies (physical strength, overall appearance and comfort, general health, sexual function and ability to go about daily activities). Patients more dissatisfied with their bodies experienced more GVHD and relapse. GVHD is associated with a sustained loss of strength and a negative body image. It is possible that depression may cause a poor body image 6 (they may not look as bad as they feel); this will require further investigation. The way QOL is self-reported may also be influenced by expectations. Patients may expect to return to the health they experienced before the pre-transplant illness and transplant; this is often a number of years earlier and therefore this may be an unrealistic expectation. 18 Normality may also be so long ago that it may be difficult for patients to remember what it was like. Normal healthy people experience occasional symptoms and healthrelated problems; the significance of these may be magnified in a patient post-transplant.
This study is the first in BMT patients to examine the association between the clinician's and patient's perception of their health. In general, the level of agreement was high but not in the areas of mental health and energy. Mental health as defined by the MOS-SF-36 is a measure of emotional state. There are a number of possible explanations as to why the clinician may not have appreciated this decrease in psychological function. The patients may have a masked depression or possibly the right questions may not be being asked at outpatient review. Alternatively, coming to be reviewed may be a positive act that makes patients feel temporarily better or the patient may subconsciously want the clinician to feel they are better than they really are, to win the clinician's approval. This latter phenomenon has been seen in patients with HIV infection and requires further investigation in this setting. Alternatively, physicians may minimise a patient's symptoms as a way of reinforcing the value of what they do or relieving the stress of caring for very ill patients. Comparison with records from their primary care physician might be illuminating and the administration of a depression inventory might help to clarify the apparent anomaly.
The disparity concerning energy/vitality is also of interest and indicates that, although patients may be physically well their energy may not return to normal levels (as defined by the patient). Alternatively, a patient's view of normal energy levels may change after transplant. It is not surprising that transplant physicians do not appreciate this as it would only be apparent on very detailed questioning.
The overall results concerning return to employment are encouraging and not different from previously reported data in other transplant groups. 7 In our study group, inability to work was not associated with time since transplant, GVHD or relapse. This may suggest that there are other, non-physical factors associated with non-employment. Similarly, of those who did return to work, about one quarter had compromised function at work, but this too did not correlate with the major complications of UD-BMT. Patients contemplating transplant need clear advice about the influence of UD-BMT on future employment. It would seem reasonable to advise that the chance of return to full-time work is good and that even if that does not occur then parttime work is a possibility.
The level of social support for the survivors was high, with the partner (present in 60% of cases) or an important relative being the major sources of support. High quality of life was correlated with the availability and adequacy of social support. However, the disparity between actual and ideal support requires explanation. It is possible that the significant other underestimates the problems of the patient or that, in a person who is chronically ill, takes the attitude that not responding to every symptom reported is best in the long run. Alternatively, living with a chronically ill person may affect one's ability to provide the support required. Research on informal caregivers of other chronically ill groups has revealed that the caregiving role can be highly demanding and stressful. 15 Indeed, high levels of psychological morbidity are frequently reported in such groups. 19 Future work should investigate the support that is actually given and should analyse the viewpoint of the patient's 'significant other', comparing this with the patient's perceptions.
Although this study did not survey sexual function in detail it seems that a significant proportion of long-term survivors are dissatisfied with their sexual function. Previous prospective studies 20, 21 have shown that the pretransplant abnormalities in sexual function remain at 3 and 12 months post-BMT; this study suggests that with further follow-up there is no substantial improvement.
In summary, many long-term survivors of UD-BMT have a very satisfactory QOL but a proportion of patients are too unwell to work. Our study indicates some patients may require considerable long-term support. Considerable further research needs to be performed on the quality of life of long-term survivors of UD-BMT. This will enable us to counsel fully patients about to undergo the procedure. As UD-BMT is associated with considerable morbidity, all clinical papers reporting the results of UD-BMT should include data concerning performance status, employment and some quality of life measure. Raw survival data are not enough; to properly compare the results of different approaches we need to examine in detail the physical and psychological morbidity of the survivors of UD-BMT.
